New Promise Neuropathy - Crunchbase Company Profile & Funding

Q: Who invested in New Promise Neuropathy?

New Promise Neuropathy has 2 investors including Baymark Partners And HCAP Partners.

Overview

New Promise Neuropathy

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About New Promise Neuropathy

CB Rank

744582

New Promise Neuropathy provides treatment for all types of neuropathy and musculoskeletal pain.

Founded

obfuscation

Private

Private Equity

Arlington, Texas, United States

1-10

www.newpromiseneuropathy.com

Health Care

Health Diagnostics

Hospital

Funding Rounds

Private Equity

OBF

obfuscation

Key People

Ali Alavi: Founder & CEO

Details

Also Known As

DFW Neuropathy

Operating Status

Active

Company Type

For Profit

Founders

Ali Alavi

About the Company

New Promise Neuropathy provides treatment for all types of neuropathy and musculoskeletal pain. New Promise Neuropathy is a comprehensive and centrally located facility that consistently adheres to evidence-based medicine. The company prioritizes holistic care, maintain excellent bedside manner, and boast a high success rate.

Phone Number

+1 682 323 5904

Contact Email

info@dfwneuropathy.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Peripheral Neuropathy Treatment

Medical treatment focused on managing nerve damage outside the brain and spinal cord, especially in extremities like feet and hands.

Diabetic Neuropathy Treatment

Specialized care for nerve damage caused by diabetes, targeting symptoms and complications from prolonged high blood sugar levels.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - New Promise Neuropathy	2	obfuscated obfuscation	Baymark Partners	Private Equity
obfuscated obfuscation	Private Equity Round - New Promise Neuropathy	2	obfuscated obfuscation	Baymark Partners	Private Equity
obfuscated obfuscation	Private Equity Round - New Promise Neuropathy	2	obfuscated obfuscation	Baymark Partners	Private Equity
obfuscated obfuscation	Private Equity Round - New Promise Neuropathy	2	obfuscated obfuscation	Baymark Partners	Private Equity
obfuscated obfuscation	Private Equity Round - New Promise Neuropathy	2	obfuscated obfuscation	Baymark Partners	Private Equity

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - New Promise Neuropathy	2	obfuscated obfuscation	Baymark Partners	Private Equity
obfuscated obfuscation	Private Equity Round - New Promise Neuropathy	2	obfuscated obfuscation	Baymark Partners	Private Equity
obfuscated obfuscation	Private Equity Round - New Promise Neuropathy	2	obfuscated obfuscation	Baymark Partners	Private Equity
obfuscated obfuscation	Private Equity Round - New Promise Neuropathy	2	obfuscated obfuscation	Baymark Partners	Private Equity
obfuscated obfuscation	Private Equity Round - New Promise Neuropathy	2	obfuscated obfuscation	Baymark Partners	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Baymark Partners	Yes	Private Equity Round - New Promise Neuropathy	Andy Waltman
Baymark Partners	Yes	Private Equity Round - New Promise Neuropathy	Andy Waltman
Baymark Partners	Yes	Private Equity Round - New Promise Neuropathy	Andy Waltman
Baymark Partners	Yes	Private Equity Round - New Promise Neuropathy	Andy Waltman
Baymark Partners	Yes	Private Equity Round - New Promise Neuropathy	Andy Waltman